LNCHC directly binds and regulates YBX1 stability to ameliorate metabolic dysfunction-associated steatotic liver disease progression.
Lu K, Cheng X, He L, Li M, Chen Q, Qian C, Zhao R, Yang L, Liu F, Liu S, Zhang T, Feng L, Wu L, Wu X, Xu N, Li Y, Wang J, Han Y, Yuan H, Liu T, Zheng M, Lu S, Li D.
Lu K, et al. Among authors: yang l.
Liver Int. 2024 Sep;44(9):2396-2408. doi: 10.1111/liv.15975. Epub 2024 Jun 7.
Liver Int. 2024.
PMID: 38847599